Make or buy decision

Retro virus products

Vironostica HIV-1 Plus O Kit
Raw material: Rs.1400
Variable expenses: Rs 16.43
Rs. 1216.43
Fixed Expenses Rs 19.12.
Total expenses Rs. 1735.55
Market Price : Rs 1325/-
It is better to buy the product and sell it in the open market
Vironostica HIV-1 Plus O Kit

Raw material cost: Rs.3600

Variable cost: Rs 16.43
Rs.3616.43
Fixed Cost Rs 19.12
Total cost Rs.3635.55
Market Price : Rs 3315
It is better to buy the product and sell it in the open market

Vironostica HIV-1 Plus O Wash Concentrate

Raw material cost Rs.20.00

Variable cost : Rs 17.43
Rs.37.43
Fixed cost Rs 19.12
Total Cost Rs.56.55
Market Price : Rs 32
It is better to buy the product and sell it in the open market

Vironostica HIV-1 Plus O DBS Elution Medium

Raw material cost Rs.30.00
Variable cost: Rs 17.43
Rs.47.43
Fixed cost Rs.19.12
Total cost Rs.66.55
Market Price : Rs.45
It is better to buy the product and sell it in the open market

Vironostica HIV-1 Kit

Raw material cost: Rs.800

Variable cost: Rs 16.13
Rs.816.43
Fixed cost Rs.19.12
Total cost Rs.837.55
Market Price : Rs
It is better to buy the product and sell it in the open market

HIV-1.Wash concentrate: (For 2 bottles)

Raw material cost: Rs. 4.00
Variable cost : Rs 7.00
Rs.11.00
Fixed cost Rs.19.12
Total cost Rs.30.12
Market Price : Rs 08
It is better to buy the product and sell it in the open market
VIDAS D –Dimer Exclusion & Miscellaneous Assays
VIDAS D –Dimer Exclusion Kit
Raw material cost: Rs.700
Variable cost: Rs 72.00
Rs.772
Fixed Cost Rs 19.12
Total cost Rs.791.12
Market Price : Rs 930
It is better to make the product and sell it in the open market
APCr-Quik Rest , activated Protein c Resistance

Raw material cost: Rs.300

Variable cost: Rs 150
Rs.450
Fixed Cost Rs 19.12
Total cost Rs.469.12
Market Price : Rs 450
It is better to buy the product and sell it in the open market
NucliSENS Products
Lysis Buffer , 2ml
Raw material cost: Rs.70.00
Variable cost: Rs 10.00
Rs.80.00
Fixed Cost Rs 19.12
Total cost Rs 99.12.
Market Price : Rs 60
It is better to buy the product and sell it in the open market
Magnetic extraction Reagents:
Raw material cost: Rs.70.00
Variable cost: Rs 12.00
Rs.82.00
Fixed Cost Rs 19.12
Total cost Rs.101.12
Market Price : Rs 175.
It is better to make the product and sell it in the open market
EsayMAG Buffer 1.

Raw material cost: Rs.275

Variable cost: Rs 75
Rs.350
Fixed Cost Rs 19.12
Total cost Rs.369.12
Market Price : Rs 400
It is better to make the product and sell it in the open market
EsayMAG Buffer 2
Raw material cost: Rs.275
Variable cost: Rs 75
Rs.345
Fixed Cost Rs 19.12
Total cost Rs.364.12
Market Price : Rs 275
It is better to buy the product and sell it in the open market
EasyMAG Magnetic silica
Raw material cost: Rs.275
Variable cost: Rs 40
Rs.315
Fixed Cost Rs 19.12
Total cost Rs.334.12

Market Price : Rs 50.

It is better to make the product and sell it in the open market
Beads Buffer
Raw material cost: Rs.50
Variable cost: Rs 30
Rs.80
Fixed Cost Rs 19.12
Total cost Rs.99.12
Market Price : Rs 100
It is up to the company to make or buy the product and sell it in the open market

Assay buffer:
Raw material cost: Rs.300
Variable cost: Rs 90
Rs.390
Fixed Cost Rs 19.12
Total cost Rs.409.12
Market Price : Rs 500
It is better to make the product and sell it in the open market
3.1: Findings
It is found that some of the existing products are not performing.
The customers of health care industry require latest products in an affordable price.
Many competitors like Biorad, BD, Roche, are providing good quality products that are
highly in demand from the pathological labs and doctors.
But, Anamol Laboratories is selling old products / me –too products which are marketed
by 30 plus competitors in the Indian diagnostic Market.
So, the company should quickly identify the needs of the customer and should
manufacture / outsource the same and satisfy the customers’ needs.

It is found that among 15 biotech products, the company is able to manufacture only 6
products.
The company will break-even after one year that is at the end of 2008.
The company aims at reducing the price of the clinical research products because of
tough competition.
3.2:Suggestion:
The company should increase the quality of clinical research products.
Biotech products are found to be numerous and the company should enter in to the
products of the future.
The products that are available in the market are of high quality hence the products to be
manufactured should be of very high quality.
Sales promotion should be increased to achieve break-even at a faster rate.
Conclusion:
The company should have a full fledged , full-time skilled person in Finance so that it can
gain strength in all finance related matters.
The company should operate it’s strategic plan which is due for implementation.

This project is aimed at knowing in which product the company should invest and in
which it should not.
It was achieved and the break-even point for the company is also found.
References:
www.anamol.net
www.expresspharmahealth.com

www.biospectrum.com
www.indiainfoline.com
Sales figures of Anamol Laboratories ltd.
Personal discussion with Ms.Bhavana Joshi General Manager, Anamol Laboratories
Pvt.Ltd
Personal discussion with Mr.Biren Patel, Manager-R&D.
www.bd.com